February 2014 | Oncology & Biotech News

Oncologists Must Help Patients Overcome Fear of Genetic Testing to Uncover Cancer Risks

March 13, 2014

In the current digital age, where all-too-personal information flows from Facebook and Twitter, it seems that the health information available through the process of genetic testing would be an idea welcomed by most of the public.

Minimizing Axillary Surgery for Patients With Node-Positive Breast Cancer

March 06, 2014

As advances in systemic therapy improve our ability to individualize breast cancer treatment, and improve response rates and outcomes, it is important to reevaluate the most appropriate form of local-regional management.

Idelalisib Shows Promising Activity in Heavily Pretreated iNHL

February 26, 2014

Treatment with the oral PI3K-delta inhibitor idelalisib produced an overall response rate of 57% with an average response duration of 12.5 months in heavily pretreated patients with indolent non-Hodgkin's lymphoma.

Study Suggests IMRT Improves Survival in Head and Neck Cancer

February 25, 2014

Intensity-modulated radiation therapy (IMRT) improved survival and reduced toxicities compared with conventional radiation treatment in patients with head and neck cancer, according to a recent database analysis.